IDEXX Laboratories (IDXX) Earnings Date, Estimates & Call Transcripts

$469.71

-0.97 (-0.21%)

(As of 07/26/2024 ET)

Upcoming Earnings Date: Aug. 6
Before Market Opens
Confirmed
Actual EPS (May. 1): $2.81 Beat By $0.13
Consensus EPS (May. 1): $2.68

IDXX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IDXX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Unstoppable Prosperity

“Generational Bull Run” Incoming

LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.

You can find out what they are by clicking here now.

IDEXX Laboratories Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate	Company Guidance
Q1 2024	2	$2.55	$2.72	$2.64
Q2 2024	2	$2.84	$2.86	$2.85
Q3 2024	2	$2.69	$2.78	$2.74
Q4 2024	2	$2.62	$2.91	$2.77
FY 2024	8	$10.70	$11.27	$10.99
Q1 2025	2	$2.96	$3.08	$3.02
Q2 2025	2	$3.00	$3.19	$3.10
Q3 2025	2	$3.13	$3.15	$3.14
Q4 2025	1	$3.16	$3.16	$3.16
FY 2025	7	$12.25	$12.58		$12.42

IDXX Earnings Date and Information

IDEXX Laboratories last announced its earnings results on May 1st, 2024. The reported $2.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.68 by $0.13. The firm had revenue of $964.10 million for the quarter, compared to analysts' expectations of $965.43 million. IDEXX Laboratories has generated $10.33 earnings per share over the last year ($10.33 diluted earnings per share) and currently has a price-to-earnings ratio of 45.5. Earnings for IDEXX Laboratories are expected to grow by 13.45% in the coming year, from $11.00 to $12.48 per share. IDEXX Laboratories has confirmed that its next quarterly earnings report will be published on Tuesday, August 6th, 2024. IDEXX Laboratories will be holding an earnings conference call on Tuesday, August 6th at 8:30 AM Eastern. Interested parties can register for or listen to the call..

IDEXX Laboratories Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
8/6/2024 (Confirmed)	-	-	-	-	-	-	-
5/1/2024	Q1 2024	$2.68	$2.81	+$0.13	$2.81	$965.43 million	$964.10 million
2/5/2024	Q4 2023	$2.12	$2.32	+$0.20	$2.32	$891.88 million	$901.60 million
11/1/2023	Q3 2023	$2.37	$2.53	+$0.16	$2.53	$926.88 million	$915.53 million
8/1/2023	Q2 2023	$2.43	$2.67	+$0.24	$2.67	$927.84 million	$943.63 million
5/2/2023	Q1 2023	$2.38	$2.55	+$0.17	$2.55	$887.36 million	$900.20 million
2/6/2023	Q4 2022	$1.92	$2.05	+$0.13	$2.05	$820.91 million	$828.60 million
Get the Latest News and Ratings for IDXX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for IDEXX Laboratories and its competitors with MarketBeat's FREE daily newsletter.
11/1/2022	Q3 2022	$2.04	$2.15	+$0.11	$2.15	$829.23 million	$841.66 million
8/2/2022	Q2 2022	$1.54	$1.56	+$0.02	$1.56	$864.26 million	$860.55 million
5/4/2022	Q1 2022	$2.25	$2.27	+$0.02	$2.27	$836.47 million	$836.55 million
2/2/2022	Q4 2021	$1.67	$1.89	+$0.22	$1.89	$781.83 million	$801.00 million
11/2/2021	Q3 2021	$1.88	$2.03	+$0.15	$2.03	$793.26 million	$810.42 million
7/30/2021	Q2 2021	$2.01	$2.34	+$0.33	$2.34	$794.64 million	$826.14 million
5/4/2021	Q1 2021	$1.72	$2.35	+$0.63	$2.35	$738.43 million	$777.71 million
2/2/2021	Q4 2020	$1.39	$2.01	+$0.62	$2.01	$680.03 million	$720.90 million
10/29/2020	Q3 2020	$1.42	$1.69	+$0.27	$1.69	$672.48 million	$721.79 million
7/31/2020	Q2 2020	$1.17	$1.72	+$0.55	$1.72	$589.98 million	$637.20 million
4/30/2020	Q1 2020	$1.20	$1.29	+$0.09	$1.29	$616.87 million	$626.30 million
1/31/2020	Q4 2019	$0.91	$1.04	+$0.13	$1.04	$600.60 million	$605.50 million
10/31/2019	Q3 2019	$1.14	$1.24	+$0.10	$1.24	$597.09 million	$605.30 million
8/1/2019	Q2 2019	$1.37	$1.43	+$0.06	$1.43	$627.10 million	$620.10 million

IDEXX Laboratories Earnings - Frequently Asked Questions

When is IDEXX Laboratories's earnings date?: IDEXX Laboratories has confirmed that its next quarterly earnings data will be published on Tuesday, August 6th, 2024. Learn more on IDXX's earnings history.
What guidance has IDEXX Laboratories issued on next quarter's earnings?: IDEXX Laboratories issued an update on its FY24 earnings guidance on Wednesday, May, 1st. The company provided earnings per share guidance of $10.82-$11.20 for the period, compared to the consensus estimate of $11.17. The company issued revenue guidance of $3.895-$3.965 billion, compared to the consensus revenue estimate of $3.99 billion.
Did IDEXX Laboratories beat their earnings estimates last quarter?: In the previous quarter, IDEXX Laboratories (NASDAQ:IDXX) reported $2.81 earnings per share (EPS) to beat the analysts' consensus estimate of $2.68 by $0.13. Learn more on analysts' earnings estimate vs. IDXX's actual earnings.
How much revenue does IDEXX Laboratories generate each year?: IDEXX Laboratories (NASDAQ:IDXX) has a recorded annual revenue of $3.66 billion.
How much profit does IDEXX Laboratories generate each year?: IDEXX Laboratories (NASDAQ:IDXX) has a recorded net income of $845.04 million. IDXX has generated $10.33 earnings per share over the last four quarters.
What is IDEXX Laboratories's price-to-earnings ratio?: IDEXX Laboratories (NASDAQ:IDXX) has a trailing price-to-earnings ratio of 45.47 and a forward price-to-earnings ratio of 42.70. The price/earnings-to-growth ratio is 3.86.
What is IDEXX Laboratories's EPS forecast for next year?: IDEXX Laboratories's earnings are expected to grow from $11.00 per share to $12.48 per share in the next year, which is a 13.45% increase.